The Potential of Fish Protein Hydrolysate Supplementation in Nile Tilapia Diets: Effects on Growth and Health Performance, Disease Resistance, and Farm Economic Analysis

Kabir MA 1 , Nandi SK 2 , Suma AY 2 , Abdul Kari Z 3 , Mohamad Sukri SA 4 , Wei LS 4 Show all authors , Al Mamun A 5 , Seguin P 6 , Herault M 6 , Khoo MI 7 , Téllez-Isaías G 8

Affiliations 

  • 1 Department of Aquaculture, Sylhet Agricultural University, Sylhet, 3100, Bangladesh. anamul.aq@sau.ac.bd
  • 2 Department of Aquaculture, Sylhet Agricultural University, Sylhet, 3100, Bangladesh
  • 3 Department of Agricultural Sciences, Faculty of Agro-Based Industry, Universiti Malaysia Kelantan, Jeli Campus, Jeli, Kelantan, 17600, Malaysia. zulhisyam.a@umk.edu.my
  • 4 Department of Agricultural Sciences, Faculty of Agro-Based Industry, Universiti Malaysia Kelantan, Jeli Campus, Jeli, Kelantan, 17600, Malaysia
  • 5 Department of Fish Health Management, Sylhet Agricultural University, Sylhet, 3100, Bangladesh
  • 6 Symrise Aqua Feed of Taste, Nutrition & Health Segment of the Symrise AG group, Clichy, 92110, France
  • 7 Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu 16150, Kubang Kerian, Kelantan, Malaysia
  • 8 Department of Poultry Science, University of Arkansas, Fayetteville, AR, 72701, USA
Appl Biochem Biotechnol, 2024 Oct;196(10):7145-7167.
PMID: 38489116 DOI: 10.1007/s12010-024-04913-7

Abstract

Fish protein hydrolysate (FPH) has shown immense potential as a dietary protein supplement and immunostimulant in aquaculture, especially in Nile tilapia production. Four isoproteic diets (30% crude protein) were prepared by including FPH at varying percentages (0%, 0.5%, 1%, and 2%). Nile tilapia fed with FPH diets for 90 days, and their growth performance, feed utilization, blood biochemistry, liver and gut morphology, and resistance against Streptococcus iniae were investigated. The findings revealed that diets physical attributes such as pellet durability index and water stability were remarkably (p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications